Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent.
about
One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin.Expansion of the Midwestern focus for human granulocytic anaplasmosis into the region surrounding La Crosse, Wisconsin.Vaccination with the ospA- and ospB-Negative Borrelia burgdorferi Strain 50772 Provides Significant Protection against Canine Lyme DiseaseBorreliacidal OspC antibody response of canines with Lyme disease differs significantly from that of humans with Lyme diseaseDetection of IFN-γ Secretion by T Cells Collected Before and After Successful Treatment of Early Lyme Disease.Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.Roadside ecology and epidemiology of tick-borne diseases.Geography, deer, and host biodiversity shape the pattern of Lyme disease emergence in the Thousand Islands Archipelago of Ontario, Canada.Significantly improved accuracy of diagnosis of early Lyme disease by peptide enzyme-linked immunosorbent assay based on the borreliacidal antibody epitope of Borrelia burgdorferi OspCRapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease.Borrelia burgdorferi in Ixodes scapularis ticks, Chicago area.Detection of Anaplasma phagocytophilum in animals by real-time polymerase chain reaction.Infection and co-infection rates of Anaplasma phagocytophilum variants, Babesia spp., Borrelia burgdorferi, and the rickettsial endosymbiont in Ixodes scapularis (Acari: Ixodidae) from sites in Indiana, Maine, Pennsylvania, and Wisconsin.
P2860
Q33825744-35D53115-8EAF-4036-9540-C8B9A966D885Q35530468-30F5E80C-ECBF-4918-892A-EE8C8797BCE5Q35773884-D696AD18-F5F0-4968-B1FF-27CFD74C3710Q35783597-30D658D7-FF40-44B7-A3F5-76E0E497F270Q36837894-A76B78C5-7A0F-4050-BB3C-055D21BA7F4AQ37099227-4B6B66AD-4AA3-4DA3-90AC-2F97F5B72A78Q37212881-88BB4483-394C-408F-A8E2-F27670CC2EC2Q37458925-E4ECAFA2-EE26-43E6-B0EA-618186F1025DQ39754996-5099A5EE-9B1D-4167-B7C5-24264C1BBCE3Q41856040-D5EEFA17-68B4-484D-9307-807BD51EB7ADQ42701878-3B601028-8582-455A-8F81-AC353C4150BFQ43778778-7FEB4923-DFA8-4753-B804-9CD044D4D48AQ53543281-9BA771D5-1D6D-42B9-BA93-C1EEF394C27F
P2860
Reassessment of a midwestern Lyme disease focus for Borrelia burgdorferi and the human granulocytic ehrlichiosis agent.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Reassessment of a midwestern L ...... anulocytic ehrlichiosis agent.
@en
Reassessment of a midwestern L ...... anulocytic ehrlichiosis agent.
@nl
type
label
Reassessment of a midwestern L ...... anulocytic ehrlichiosis agent.
@en
Reassessment of a midwestern L ...... anulocytic ehrlichiosis agent.
@nl
prefLabel
Reassessment of a midwestern L ...... anulocytic ehrlichiosis agent.
@en
Reassessment of a midwestern L ...... anulocytic ehrlichiosis agent.
@nl
P2093
P2860
P1476
Reassessment of a midwestern L ...... anulocytic ehrlichiosis agent.
@en
P2093
Steven D Lovrich
Steven M Callister
William A Agger
P2860
P304
P356
10.1128/JCM.40.6.2070-2073.2002
P407
P50
P577
2002-06-01T00:00:00Z